Document


 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
____________________ 
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 ____________________
Date of Report (Date of earliest event reported): January 31, 2019
Accenture plc
(Exact name of Registrant as specified in its charter)
 
Ireland
 
001-34448
 
98-0627530
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)
1 Grand Canal Square,
Grand Canal Harbour,
Dublin 2, Ireland
(Address of principal executive offices)
Registrant’s telephone number, including area code: (353) (1) 646-2000
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨
 




Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
As previously reported by Accenture plc (“Accenture”), on January 10, 2019, David Rowland became interim chief executive officer and a member of Accenture’s Board of Directors (the “Board”) and KC McClure became Accenture’s chief financial officer. On January 31, 2019, the Compensation Committee of the Board approved the following new compensation arrangements for Mr. Rowland and Ms. McClure in connection with their new roles:

•
Effective as of March 1, 2019, Mr. Rowland was granted additional equity awards composed of a target number of restricted share units (“RSUs”) with a fair market value of $4,400,000 as of the date of grant (with a maximum number of RSUs equal to 150% of that number) under Accenture’s 2019 Key Executive Performance Share Program (the “Key Executive Program”) and RSUs with a fair market value of $2,245,000 as of the date of grant under Accenture’s 2019 Leadership Performance Equity Award Program.

•
Effective as of February 1, 2019, Ms. McClure’s annual base salary was increased to $975,000 and her target annual bonus for fiscal 2019 was increased to 100.5% of her base compensation earned during fiscal 2019. In addition, effective as of March 1, 2019, she was granted an additional target number of RSUs with a fair market value of $930,000 as of the date of grant (with a maximum number of RSUs equal to 150% of that number) under the Key Executive Program.

The equity awards are subject to the standard terms and conditions, except that, in recognition of Mr. Rowland’s service as interim chief executive officer, his additional Key Executive Program award is not subject to a service vesting requirement.

Item 5.07 Submission of Matters to a Vote of Security Holders.
On February 1, 2019, Accenture held its 2019 annual general meeting of shareholders (“Annual Meeting”). Accenture’s shareholders approved each of the following proposals considered at the Annual Meeting. The following chart sets forth the number and percentage of votes cast for and against, and the number of abstention votes and broker non-votes, with respect to each proposal voted upon by Accenture’s shareholders:
 
 
 
For
 
Against
 
Abstained
 
Broker
Non-Votes
1.
To re-appoint the following directors:
 
 
 
 
 
 
 
 
 
 
 
Jaime Ardila
 
454,228,080

99.84
%
 
748,569

0.16
%
 
502,399

 
71,108,465

 
Herbert Hainer
 
454,238,610

99.83
%
 
766,184

0.17
%
 
474,254

 
71,108,465

 
Marjorie Magner
 
448,045,545

98.54
%
 
6,640,760

1.46
%
 
792,743

 
71,108,465

 
Nancy McKinstry
 
450,229,918

99.02
%
 
4,446,567

0.98
%
 
802,563

 
71,108,465

 
Gilles C. Pélisson
 
450,372,304

98.99
%
 
4,610,781

1.01
%
 
495,963

 
71,108,465

 
Paula A. Price
 
450,950,467

99.17
%
 
3,757,617

0.83
%
 
770,964

 
71,108,465

 
Venkata (Murthy) Renduchintala
 
453,194,103

99.62
%
 
1,747,709

0.38
%
 
537,236

 
71,108,465

 
David Rowland *
 
423,602,231

93.17
%
 
31,043,013

6.83
%
 
833,804

 
71,108,465

 
Arun Sarin
 
454,126,776

99.82
%
 
832,925

0.18
%
 
519,347

 
71,108,465

 
Frank K. Tang
 
454,221,700

99.90
%
 
473,633

0.10
%
 
783,715

 
71,108,465

 
Tracey T. Travis
 
454,345,973

99.86
%
 
643,402

0.14
%
 
489,673

 
71,108,465

2.
To approve, in a non-binding vote, the compensation of Accenture’s named executive officers
 
423,602,231

93.17
%
 
31,043,013

6.83
%
 
833,804

 
71,108,465

3.
To ratify, in a non-binding vote, the appointment of KPMG LLP (“KPMG”) as Accenture’s independent auditors and to authorize, in a binding vote, the Audit Committee of the Board to determine KPMG’s remuneration
 
516,959,487

98.26
%
 
9,171,455

1.74
%
 
456,571

 
—





4.
To grant the Board the authority to issue shares under Irish law
 
521,442,105

99.20
%
 
4,194,261

0.80
%
 
951,147

 
—

5.
To grant the Board the authority to opt-out of pre-emption rights under Irish law
 
522,327,682

99.42
%
 
3,053,915

0.58
%
 
1,205,916

 
—

6.
To determine the price range at which Accenture can re-allot shares that it acquires as treasury shares under Irish law
 
523,613,719

99.65
%
 
1,864,261

0.35
%
 
1,109,533

 
—

_______________

*
Pierre Nanterme, who was previously nominated for election at the Annual Meeting, resigned from the Board, effective on January 10, 2019, for health reasons. The Board designated David Rowland, Accenture’s newly appointed interim chief executive officer and director, as a director nominee. Accordingly, as stated in Accenture’s proxy statement supplement, dated January 15, 2019, any shares represented at the Annual Meeting by proxy cards or voting instructions were not voted for Mr. Nanterme, but were instead voted with respect to the election of Mr. Rowland as a director pursuant to the discretionary voting authority granted to the proxies. The number of shares voted FOR the election of Mr. Rowland represent only those shares which voted FOR all matters presented at the meeting, and therefore reflects the same vote results as proposal 2.





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
 
Date: February 4, 2019
ACCENTURE PLC
 
 
 
 
 
By:
 
/s/ Joel Unruch   
 
Name:
 
Joel Unruch
 
Title:
 
Corporate Secretary